Pharmaceuticals & Healthcare

Recent Posts

Fulford’s parent Dashtag rethinks delisting, stock falls by 20%

PublicDomainPictures / Pixabay

Fulford (India)’s parent Dashtag, a subsidiary of Merck & Co.  has postponed its delisting plans, a decision it has attributed to a sharp rise in Fulford’s share. But a reference to Sebi’s decision to amend the delisting regulations indicates some influence from that side as well. Shareholders reacted with dismay, sending the stock down by 20%on Tuesday to Rs 1,417.3–locked at the lower end of the circuit filter. Dashtag informed Fulford in a letter that it has received all approvals needed for it to make an open offer. Continue Reading →

Filed under: , , , , , , ,